Medexus Pharmaceuticals Inc.
MEDXF
$1.77
-$0.01-0.56%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.78% | -64.24% | -46.43% | -59.79% | -11.43% |
| Total Receivables | -36.39% | -42.41% | -48.94% | 7.37% | 9.37% |
| Inventory | 23.83% | 53.58% | 45.02% | 34.68% | 22.57% |
| Prepaid Expenses | -29.40% | -45.02% | -32.10% | -18.08% | 58.82% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -84.27% | -82.72% | -83.23% | 0.26% | 99.49% |
| Total Current Assets | -9.94% | -19.23% | -17.67% | -0.65% | 19.70% |
|
|
|||||
| Total Current Assets | -9.94% | -19.23% | -17.67% | -0.65% | 19.70% |
| Net Property, Plant & Equipment | -15.54% | -18.23% | -14.63% | -13.46% | -11.54% |
| Long-term Investments | -3.88% | 0.09% | -1.57% | -0.06% | 1.15% |
| Goodwill | -3.88% | 0.09% | -1.57% | -0.06% | 1.15% |
| Total Other Intangibles | -10.69% | -9.28% | -9.33% | -8.86% | -7.30% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.88% | 11.34% | 17.05% | 18.16% | 446.81% |
| Total Assets | -8.98% | -12.52% | -11.75% | -3.47% | 9.61% |
|
|
|||||
| Total Accounts Payable | -8.31% | 6.71% | 1.70% | -23.71% | 56.61% |
| Total Accrued Expenses | -- | -- | -- | 52.56% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.71% | -63.28% | -65.10% | -63.14% | -76.87% |
| Total Finance Division Other Current Liabilities | 10.02% | -21.16% | -12.45% | -1.64% | 1.25% |
| Total Other Current Liabilities | 10.02% | -21.16% | -12.45% | -1.64% | 1.25% |
| Total Current Liabilities | -0.19% | -32.51% | -34.60% | -20.68% | -34.05% |
|
|
|||||
| Total Current Liabilities | -0.19% | -32.51% | -34.60% | -20.68% | -34.05% |
| Long-Term Debt | -40.65% | 7.08% | 19.67% | 26.21% | 7,466.94% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -26.62% | -23.89% | -12.39% | -40.80% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -10.20% | -10.23% | -10.49% | -10.64% | -8.36% |
| Total Liabilities | -13.71% | -22.02% | -20.45% | -9.70% | -0.06% |
|
|
|||||
| Common Stock & APIC | 0.48% | 10.69% | 10.14% | 10.05% | 10.45% |
| Retained Earnings | 5.48% | 3.56% | 1.72% | -0.33% | 8.30% |
| Treasury Stock & Other | -7.04% | 2.28% | 10.74% | 0.24% | -1.47% |
| Total Common Equity | 11.97% | 50.60% | 43.38% | 35.08% | 91.61% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.97% | 50.60% | 43.38% | 35.08% | 91.61% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.97% | 50.60% | 43.38% | 35.08% | 91.61% |
|
|
|||||